Paris Court Backs Align in Patent Fight, Orders Rival to Pull Torque Ridges in Europe
ALGN sits 15% above its 52-week low of $128.65 on light trading volume (0.3× avg).
Summary
A Paris court ruled that Angelalign's Torque Ridges infringe an Align Technology patent, a legal win for Align against its main Chinese clear-aligner rival in Europe. Angelalign must comply with the ruling, including returning product, and said it had already discontinued Torque Ridges in Europe and replaced them with a feature it calls Pressure Points. Angelalign added that customers outside Europe are unaffected, so the geographic scope of the win is limited to the European market. The ruling reinforces Align's intellectual-property position against a lower-cost competitor, though the direct revenue impact is modest given Angelalign's limited European footprint. This lands as Align faces revived US antitrust claims from an appeals court on October 5, so the legal picture cuts both ways. Align's next earnings report will show whether European share holds against Angelalign's replacement product.
At the time of this announcement, ALGN was trading at $148.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.5B. The 52-week trading range was $128.65 to $200.44. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.